IP Library Granted Patent US 7,119,070
Granted Patent B2
US 7,119,070 · App. 10/427,715 · Granted Oct 10, 2006

Antimicrobial theta defensins, analogs thereof, and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,119,070
App. No.
10/427,715
Granted
Oct 10, 2006
Kind
B2
Abstract

The invention provides theta defensin analogs having antimicrobial activity. The invention also provides a method of reducing or inhibiting growth or survival of a microorganism in an environment capable of sustaining the growth or survival of the microorganism, comprising administering an effective amount of a theta defensin analog to the environment, thereby reducing or inhibiting the growth or survival of the microorganism.

Claims (12)

1. A theta defensin analog comprising SEQ ID NO:25.

2. A pharmaceutical composition, comprising the theta defensin analog of claim 1 and a pharmaceutically acceptable carrier.

3. A method of reducing or inhibiting growth or survival of a microorganism in an environment capable of sustaining the growth or survival of the microorganism, comprising administering an effective amount of the theta defensin analog claim 1 to said environment, thereby reducing or inhibiting of the growth or survival of the microorganism.

4. The method of claim 3 , wherein said environment is a food or food product.

5. The method of claim 3 , wherein said environment is a solution.

6. The method of claim 5 , wherein said solution is a contact lens solution.

7. The method of claim 5 , wherein said solution is an eye wash solution.

8. The method of claim 3 , wherein said environment is an inanimate object comprising a surface.

9. The method of claim 3 , wherein said environment is a mammal.

10. The method of claim 3 , wherein said administration is topical.

11. The method of claim 3 , wherein said administration is by injection.

12. The method of claim 3 , wherein said administration is oral.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 17, 2010
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024844/0799 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jul 18, 2008
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021260/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2003
From: SELSTED, MICHAEL E.; TRAN, DAT Q.
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 014020/0655 →